Jeffrey M. Jonas

Director, President & Chief Executive Officer at SAGE Therapeutics, Inc.

Jeffrey M. Jonas

Jeffrey M. Jonas

Director, President & Chief Executive Officer at SAGE Therapeutics, Inc.

Overview
Career Highlights

Shire Regenerative Medicine, Inc.
SAGE Therapeutics, Inc.
Evogen, Inc.

RelSci Relationships

817

Number of Boards

9

Birthday

1953

Age

66

Relationships
RelSci Relationships are individuals Jeffrey M. Jonas likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Third Rock Ventures LLC

Relationship likelihood: Strong

Co-Founder at Tal Medical, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Aevi Genomic Medicine, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Director at AVAX Technologies, Inc.

Relationship likelihood: Strong

Former Senior Vice President, Chief Financial Officer & Treasurer at Alkermes Plc

Relationship likelihood: Strong

Member, Board of Directors at SAGE Therapeutics, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Elucida Oncology, Inc.

Relationship likelihood: Strong

Former Chief Executive Officer & Executive Director at NetScientific Plc

Relationship likelihood: Strong

Partner & Chief Technology Officer at Third Rock Ventures LLC

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Decibel Therapeutics, Inc.

Relationship likelihood: Strong

Paths to Jeffrey M. Jonas
Potential Connections via
Relationship Science
You
Jeffrey M. Jonas
Director, President & Chief Executive Officer at SAGE Therapeutics, Inc.
Education
MD

Harvard Medical School (HMS) is the graduate medical school of Harvard University. It is located in the Longwood Medical Area of the Mission Hill neighborhood of Boston, Massachusetts.The school was founded by John Warren on September 19, 1782, with Benjamin Waterhouse, and Aaron Dexter.

BA Unknown

Amherst College educates men and women of exceptional potential from all backgrounds so that they may seek, value, and advance knowledge, engage the world around them, and lead principled lives of consequence. Amherst brings together the most promising students, whatever their financial need, in order to promote diversity of experience and ideas within a purposefully small residential community. Working with faculty, staff, and administrators dedicated to intellectual freedom and the highest standards of instruction in the liberal arts, Amherst undergraduates assume substantial responsibility for undertaking inquiry and for shaping their education within and beyond the curriculum. Amherst College is committed to learning through close colloquy and to expanding the realm of knowledge through scholarly research and artistic creation at the highest level. Its graduates link learning with leadership—in service to the College, to their communities, and to the world beyond.

Career History
Director, President & Chief Executive Officer
2013 - Current

SAGE Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA.

President of Regenerative Medicine
Prior - 2013

Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland.

President-Regenerative Medicine Division
2008 - 2013

Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986

Boards & Committees
Chairman, President & Chief Technology Officer
Prior

Evogen is a global biological detection system company, and is the leading developer and manufacturer of High Definition PCR™ (HD PCR) molecular diagnostics systems, meeting the needs of a diverse range of markets including biodefense, clinical, research, animal health, agbio, food and water safety, indoor air quality, environmental monitoring and forensics.Through its core expertise and patented technologies in the collection, concentration, preparation and detection of clinical and environmental biological samples, the company have developed product offerings that range from stand-alone modules and assay kits through to fully integrated units for dedicated diagnostic tasks. The company are developing both semi- and fully-automated rapid HD PCR diagnostic systems and Automated Sample Preparation (ASP) technology for sample preparation.

Transactions
Details Hidden

SAGE Therapeutics, Inc. issued Common Stock

Details Hidden

SAGE Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

SAGE Therapeutics, Inc. raised money in a private placement transaction

Investments
Details Hidden

Evogen is a global biological detection system company, and is the leading developer and manufacturer of High Definition PCR™ (HD PCR) molecular diagnostics systems, meeting the needs of a diverse range of markets including biodefense, clinical, research, animal health, agbio, food and water safety, indoor air quality, environmental monitoring and forensics.Through its core expertise and patented technologies in the collection, concentration, preparation and detection of clinical and environmental biological samples, the company have developed product offerings that range from stand-alone modules and assay kits through to fully integrated units for dedicated diagnostic tasks. The company are developing both semi- and fully-automated rapid HD PCR diagnostic systems and Automated Sample Preparation (ASP) technology for sample preparation.

Details Hidden

SAGE Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jeffrey M. Jonas. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jeffrey M. Jonas's profile does not indicate a business or promotional relationship of any kind between RelSci and Jeffrey M. Jonas.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/jeffrey-m-jonas-3143828
  • https://relationshipscience.com/person/jeffrey-m-jonas-3143828